CIK 0001759425
- Large accelerated filer
Mirum Pharmaceuticals, Inc.
Sign in to watch- Ticker
- MIRM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 831281555
- Phone
- +1 650-667-4085
- Business address
- 989 EAST HILLSDALE BOULEVARD, SUITE 300, FOSTER CITY, CA, 94404
- 4 Option exercise CHIEF FINANCIAL OFFICER acquired 18,334 shares (option exercise)
- 4 Open-market buy Director bought 230 shares at $41.58 ($9,563)
- 4 Option exercise CHIEF EXECUTIVE OFFICER acquired 34,013 shares (option exercise)
- 4 Open-market sale SVP, GLOBAL CONTROLLER sold 375 shares at $34.00 ($12,750)
- 4 Planned sale CHIEF SCIENTIFIC OFFICER sold 30,559 shares at $34.00 ($1,039,006)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Planned sale Director sold 5,000 shares at $25.68 ($128,400)
- 4 Derivatives Options or other derivatives
- 4 Grant or award CHIEF FINANCIAL OFFICER acquired 470 shares (grant or award)
- 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 817 shares (grant or award)
- 4 Grant or award CHIEF SCIENTIFIC OFFICER acquired 94 shares (grant or award)
- 4 Open-market buy CHIEF FINANCIAL OFFICER bought 2,000 shares at $24.80 ($49,600)
- 4 Open-market sale PRESIDENT AND COO sold 4,303 shares at $25.80 ($111,017)
- 4 Open-market sale PRESIDENT AND COO sold 1,379 shares at $20.62 ($28,438)
- 4 Open-market sale CHIEF SCIENTIFIC OFFICER sold 1,379 shares at $20.62 ($28,438)
Page 7 of 18 · 356 filings